Update COVID-19 Situation
As the situation with COVID–19 is dynamic we will continue to make proactive decisions that are grounded in care for our customers and patients. This means a different interpretation in the flow of goods that would normally apply.
At Future Diagnostics, safety and well-being of our employees and customers are our top priority. Like you, we have been astonished by the fast and growing impact of the global spread of Coronavirus (SARS-CoV-2).
Given the intense focus on steps being taken by organizations to halt the spread of the virus, we would like to update you on Future Diagnostics policy in relation to the services we offer to you as end-user/customer of our STAT IO-I-PTH System.
Successful FDA inspection at Future Diagnostics
Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.
ISO 13485:2016 certification
We are proud to announce that Future Diagnostics Solutions has now successfully transitioned its Quality Management System to ISO 13485:2016. The scope of the approval is applicable to research, development, manufacturing, sales and distribution of in vitro diagnostic medical devices and accessories, including R&D services and contract manufacturing. Future Diagnostics is ISO 13485 certified since 2004.